Ipilimumab Interactions
There are 655 drugs known to interact with ipilimumab, along with 10 disease interactions. Of the total drug interactions, 24 are major, and 631 are moderate.
- View all 655 medications that may interact with ipilimumab
- View ipilimumab disease interactions (10)
Most frequently checked interactions
View interaction reports for ipilimumab and the medicines listed below.
- Abraxane (paclitaxel protein-bound)
- Abstral (fentanyl)
- Acidophilus Probiotic Blend (lactobacillus acidophilus)
- Activated Charcoal (charcoal)
- Adderall (amphetamine / dextroamphetamine)
- Adriamycin (doxorubicin)
- Aspirin Low Strength (aspirin)
- Bactrim (sulfamethoxazole / trimethoprim)
- Coenzyme Q10 (ubiquinone)
- Colace (docusate)
- Crestor (rosuvastatin)
- DHEA (dehydroepiandrosterone)
- Eliquis (apixaban)
- Glucosamine & Chondroitin with MSM (chondroitin / glucosamine / methylsulfonylmethane)
- Iodides (sodium iodide)
- Keytruda (pembrolizumab)
- Mekinist (trametinib)
- Metoprolol Succinate ER (metoprolol)
- Metoprolol Tartrate (metoprolol)
- Opdivo (nivolumab)
- Paracetamol (acetaminophen)
- Plavix (clopidogrel)
- Reglan (metoclopramide)
- Senna Plus (docusate/senna)
- Trelegy Ellipta (fluticasone / umeclidinium / vilanterol)
- Tylenol (acetaminophen)
- Vitamin B Complex 100 (multivitamin)
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
- Zyrtec (cetirizine)
Ipilimumab disease interactions
There are 10 disease interactions with ipilimumab which include:
- colitis
- dermatitis
- endocrinopathies
- hepatitis
- HSCT
- immune system disorder
- ocular disease
- hepatic impairment
- organ transplant
- pneumonitis
Report options
More about ipilimumab
- ipilimumab consumer information
- Compare alternatives
- Reviews (5)
- Side effects
- Dosage information
- During pregnancy
- Drug class: anti-CTLA-4 monoclonal antibodies
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Yervoy
Yervoy (ipilimumab) is a cancer treatment used for lung cancer, melanoma, renal cell carcinoma ...
Alecensa
Alecensa (alectinib) is an oral kinase inhibitor that may be used to treat certain types of ...
Lumakras
Lumakras is used to treat KRAS G12C-mutated non-small cell lung cancer (NSCLC) or colorectal cancer ...
Opdivo Qvantig
Opdivo Qvantig is used to treat adults with melanoma, non-small cell lung cancer, renal cell ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Avastin
Avastin is used to brain tumors and cancers of the kidney, colon, rectum, or lung. Learn about side ...
Xeloda
Xeloda is used to treat breast and colorectal cancers. Learn about side effects, interactions and ...
Oxaliplatin
Oxaliplatin (Eloxatin) is a cytotoxic chemotherapy drug used to treat stage III colon cancer and ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
